Home Comparison of TEST 1 with SRS 100 and ICSH reference method for the measurement of the length of sedimentation reaction in blood
Article
Licensed
Unlicensed Requires Authentication

Comparison of TEST 1 with SRS 100 and ICSH reference method for the measurement of the length of sedimentation reaction in blood

  • Sebahat Ozdem , Halide S. Akbas , Levent Donmez and Meral Gultekin
Published/Copyright: September 21, 2011

Abstract

Background: We evaluated the measurement of length of sedimentation reaction in blood (LSRB) by TEST 1 and compared the results with those for the Westergren and Sed Rate Screener 100 (SRS 100) methods.

Methods: LSRB was measured in 113 paired blood samples.

Results: TEST 1 correlated significantly with the Westergren (r=0.94) and SRS 100 (r=0.90) methods with low bias (−0.29 and −1.92mm/h, respectively) and limits of agreement (−14.5 to 13.9, and −23.4 to 19.6mm/h, respectively). Hematocrit (Htc) correlated negatively with LSRB in TEST 1 (r=−0.54) and SRS 100 (r=−0.53) only in samples with high Htc (≥35%). The bias and limits of agreement between TEST 1 and Westergren in samples with low (−1.46 and −22.3 to 19.3mm/h) and high (0.43 and −7.29 to 8.14mm/h) Htc were comparable to those between SRS 100 and Westergren (1.83 and −27.2 to 30.9mm/h for low, 0.71 and −7.27 to 8.70mm/h for high Htc samples). Total protein and fibrinogen correlated similarly with LSRB in both TEST 1 (r=0.23 and 0.48, respectively) and SRS 100 (r=0.30 and 0.51, respectively).

Conclusions: The findings suggested that TEST 1 is a reliable, precise and accurate system for measurement of LSRB in clinical laboratories with high workload.


Corresponding author: Sebahat Ozdem, Akdeniz University, Medical Faculty, Central Laboratory, Clinical Biochemistry Unit, Arapsuyu 07070, Antalya, Turkey Phone: +90-242-2274343 ext 33252, Fax: +90-242-2272535,

References

1. International Council for Standardization in Haematology. ICSH recommendations for measurement of erythrocyte sedimentation rate. J Clin Pathol 1993;46:198–203.10.1136/jcp.46.3.198Search in Google Scholar PubMed PubMed Central

2. Sox HC, Liang MH. The erythrocyte sedimentation rate. Ann Intern Med 1986; 4:515–23.Search in Google Scholar

3. Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994; 21:1177–8.Search in Google Scholar

4. Westergren A. Studies of the suspension stability of the blood in pulmonary tuberculosis. Acta Med Scan 1921; 54:247–82.10.1111/j.0954-6820.1921.tb15179.xSearch in Google Scholar

5. National Committee for Clinical Laboratory Standards. Reference and selected procedure for erythrocyte sedimentation rate (ESR) test. Approved standard, 4th ed. H2-A4. Villanova, PA: NCCLS, 2000.Search in Google Scholar

6. Patton WN, Meyer PJ, Stuart J. Evaluation of sealed vacuum extraction method (Seditainer) for measurement of erythrocyte sedimentation rate. J Clin Pathol 1989; 42:313–7.10.1136/jcp.42.3.313Search in Google Scholar PubMed PubMed Central

7. Plebani M, De Toni S, Sanzari MC, Bernardi D, Stockreiter E. The TEST1 automated system: a new method for measuring the erythrocyte sedimentation rate. Am J Clin Pathol 1998; 110:334–40.10.1093/ajcp/110.3.334Search in Google Scholar PubMed

8. Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307–10.Search in Google Scholar

9. Plebani M. Erythrocyte sedimentation rate: innovative techniques for an obsolete test? Clin Chem Lab Med 2003; 41:115–6.10.1515/CCLM.2003.019Search in Google Scholar PubMed

10. Romero A, Munoz M, Ramirez G. Length of sedimentation reaction in blood: a comparison of the Test 1 ESR system with the ICSH reference method and the Sedisystem 15. Clin Chem Lab Med 2003; 41:232–7.10.1515/CCLM.2003.037Search in Google Scholar PubMed

11. de Jonge N, Sewkaransing I, Slinger J, Rijsdijk JJ. Erythrocyte sedimentation rate by the Test-1 analyzer. Clin Chem 2000; 46:881–2.10.1093/clinchem/46.6.881Search in Google Scholar

12. Plebani M, Piva E. Erythrocyte sedimentation rate. Use of fresh blood for quality control. Am J Clin Pathol 2002; 117:621–6.10.1309/QB1G-6FRR-DNWX-BKQ9Search in Google Scholar PubMed

13. Giavarina D, Dall'Olio G, Soffiati G. Method comparison of automated systems for the erythrocyte sedimentation rate. Am J Clin Pathol 1999; 112:721–2.10.1093/ajcp/112.5.721Search in Google Scholar PubMed

14. Arezzini C, Ricci A. Method comparison of automated systems for the erythrocyte sedimentation rate – more study needed. Am J Clin Pathol 1999; 112:722–4.10.1093/ajcp/112.5.722Search in Google Scholar PubMed

15. Fabry TL. Mechanism of erythrocyte aggregation and sedimentation. Blood 1987; 70:1572–6.10.1182/blood.V70.5.1572.1572Search in Google Scholar

16. Bedell SE, Bush BT. Erythrocyte sedimentation rate, from folklore to facts. Am J Med 1985; 78:1001–9.10.1016/0002-9343(85)90224-4Search in Google Scholar

17. Ballou SP, Kushner I. Laboratory evaluation of inflammation. In: Kelly W, Harris E, Ruddy S, Sledge C, editors. Textbook of rheumatology, 5th ed. Philadelphia, PA: Saunders, 1996:699–706.Search in Google Scholar

18. Hung WT, Collings AF, Low J. Erythrocyte sedimentation rate studies in whole human blood. Phys Med Biol 1994; 39:1855–73.10.1088/0031-9155/39/11/005Search in Google Scholar PubMed

19. Piva E, Sanzari MC, Servidio G, Plebani M. Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): variations with sex and age and reference limits. Clin Chem Lab Med 2001; 39:451–4.10.1515/CCLM.2001.071Search in Google Scholar PubMed

20. Horsti J, Kovanen M. Using EDTA as an anticoagulant for ESR to replace citrate. Klin Lab 2000; 4:97–100.Search in Google Scholar

21. Koepke JA, van Assendelft OW, Bull BS, Richardson-Jones A. Standardization of EDTA anticoagulation of blood counting procedures. Labmedica 1989; 5:15–7.Search in Google Scholar

Received: 2005-11-30
Accepted: 2006-1-4
Published Online: 2011-9-21
Published in Print: 2006-4-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Natriuretic peptides and evidence-based quality specifications
  2. Preanalytical variability: the dark side of the moon in laboratory testing
  3. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
  4. Hepatorenal syndrome
  5. Modified Levey-Jennings charts for calculated laboratory tests
  6. Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study
  7. The exponentially weighted moving average (EWMA) rule compared with traditionally used quality control rules
  8. Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results: application to Fibrotest® and Actitest® scores
  9. Comparison of TEST 1 with SRS 100 and ICSH reference method for the measurement of the length of sedimentation reaction in blood
  10. Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays
  11. Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay
  12. Erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alanine
  13. Matrix metalloproteinases and their inhibitors in different acute stroke subtypes
  14. Pyrosequencing protocol requiring a unique biotinylated primer
  15. Detection of antibodies against 60-, 65- and 70-kDa heat shock proteins in paediatric patients with various disorders using Western blotting and ELISA
  16. Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-tandem mass spectrometry
  17. Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients
  18. Stepwise strategies in analysing haematuria and leukocyturia in screening
  19. Elevation of serum cerebral injury markers correlates with serum choline decline after coronary artery bypass grafting surgery
  20. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study
  21. Release of anandamide from blood cells
  22. Rapid decrease in plasma D-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients
  23. Evaluation of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatography/tandem mass spectrometry
  24. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases
  25. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens
  26. Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome
  27. The dilemma of invasive and non-invasive investigations for adult and paediatric non-alcoholic fatty liver disease: has the time come for a new biochemical marker?
  28. Is cystatin C a reliable renal marker in trauma?
  29. On the independence of intraindividual reference values
  30. Sixth International Symposium on Molecular Diagnostics, Graz, Austria, May 25-27, 2006
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.075/html
Scroll to top button